Ticker | CBRE | Earnings Date | July 29, 2026 — 8:30 AM ET |
Sector | Commercial Real Estate Services | Prepared | July 28, 2026 |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) | Last Earnings | April 23, 2026 (Q1 2026) |
Key Takeaway: Setup is constructive but not a layup — consensus has drifted modestly lower since Q1 earnings, the bar is achievable, and the biggest swing factor is whether infrastructure / data center momentum sustains the pace set in Q1.
Bar: Consensus Adjusted EPS for Q2 2026 sits at $1.48 (down from $1.52 immediately post-Q1 print), implying roughly 23% YoY growth vs. the $1.20 reported in Q2 2025 — a meaningful but not stretched bar given management's explicit commentary that Q2 pipelines entered the quarter "stronger than expected." Revenue consensus of ~$11.2B represents ~16% YoY growth, broadly in line with Q1's trajectory.
Guidance / Tone: Management raised full-year 2026 core EPS guidance to $7.60–$7.80 (from $7.30–$7.60) on the Q1 call, citing outperformance in Q1, early Q2 momentum, and strong pipelines across all segments. The tone was notably confident: Advisory SOP growth upgraded to high-teens, BOE SOP growth guided to ~25%, and the critical infrastructure services business line (data centers, telecom, power) expected to grow in excess of 60% for the full year. No post-earnings guidance revision has been issued since April 23.
Estimate Trajectory: Q2 2026 Adjusted EPS estimates have drifted ~2.5% lower since the post-Q1 baseline ($1.52 → $1.48), while FY2026 EPS has slipped ~0.5% ($7.76 → $7.72). The modest downward drift likely reflects macro uncertainty and some conservatism around the timing of development profits (Q1 pulled forward Trammell Crow land gains), rather than any fundamental deterioration. The gap between current consensus and the FY guidance midpoint ($7.70) is negligible, suggesting estimates are broadly tracking guidance.
Stock Setup: CBRE has underperformed both XLRE (+4.1%) and the S&P 500 (+4.3%) since the Q1 print, with the stock down ~1.5% on an indexed basis as of July 28. The NTM P/E has compressed from ~25x to ~21x over six months, suggesting the market has de-rated the stock despite the guidance raise — creating a potentially attractive setup if Q2 confirms the infrastructure growth narrative. At ~21x NTM earnings, CBRE trades at a discount to its recent history and below where the quality of the earnings mix arguably warrants.
Wildcard: The single biggest swing factor is the pace of critical infrastructure services revenue in Q2. This business line (data centers, telecom, power via Pearce) grew 71% YoY in Q1 and is expected to grow 60%+ for the full year. Any acceleration or deceleration vs. that pace — combined with the seasonality caveat management flagged for Pearce — could move estimates materially. A secondary wildcard is whether capital markets (property sales, mortgage origination) maintained Q1's exceptional momentum (+43% and +53% YoY, respectively) into Q2 amid macro uncertainty.
Key Takeaway: Consensus is a moderately achievable bar — estimates have drifted slightly lower since Q1 earnings, and management's own commentary on Q2 pipeline strength suggests the Street may be conservative. Adjusted EPS is the primary swing factor; revenue is secondary given the high pass-through cost mix in BOE.
KPI | Q1 2026 Actual (Last Quarter) | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | FY2026 Guidance | Consensus vs. Guidance |
Adjusted EPS — Diluted | $1.61 | $1.20 | $1.48 | +23.3% | $7.60–$7.80 (FY) | FY consensus $7.72 vs. midpoint $7.70; +0.3% |
Total Revenue | $10.53B | $9.72B | $11.24B | +15.6% | No specific Q2 guidance; FY consensus $46.8B | N/A — no Q2 revenue guidance issued |
Advisory Services Revenue | $2.02B | $1.96B | $2.23B | +13.8% | High-teens SOP growth (FY) | N/A — SOP guidance, not revenue |
Project Management Revenue | $0.91B | $0.83B | $0.95B | +14.5% | Unchanged from prior guidance | N/A — no specific revenue guidance |
Adjusted EBITDA | $831M | $626M | $765M | +22.2% | FY consensus ~$3.74B | N/A — no specific EBITDA guidance |
Source: Visible Alpha Consensus and Actuals Data. All consensus figures as of July 28, 2026. Q1 2026 actuals and Q2 2025 actuals from Visible Alpha reported figures.
KPI 1: Adjusted EPS — Diluted
Quarter | Reported | Consensus | Surprise % | Result |
Q1 2026 | $1.61 | $1.14 | +41.2% | Large Beat |
Q4 2025 | $2.69 | $2.69 | ~0% | In Line |
Q3 2025 | $1.60 | $1.46 | +9.9% | Beat |
Q2 2025 | $1.20 | $1.07 | +12.1% | Beat |
Q1 2025 | $0.89 | $0.76 | +17.1% | Beat |
Q4 2024 | $2.28 | $2.23 | +2.3% | Beat |
Q3 2024 | $1.19 | $1.06 | +12.2% | Beat |
Q2 2024 | $0.83 | $0.70 | +18.6% | Beat |
Pattern: CBRE has beaten Adjusted EPS consensus in 7 of the last 8 quarters, with an average positive surprise of ~14% — the Q1 2026 beat of +41% was exceptional and driven partly by the pull-forward of Trammell Crow land development profits. The consistent beat pattern suggests the Street tends to under-model CBRE, though the magnitude of Q1's beat is unlikely to repeat.
KPI 2: Total Revenue
Quarter | Reported | Consensus | Surprise % | Result |
Q1 2026 | $10.53B | $10.23B | +2.9% | Beat |
Q4 2025 | $11.59B | $11.66B | -0.6% | Slight Miss |
Q3 2025 | $10.22B | $10.05B | +1.7% | Beat |
Q2 2025 | $9.72B | $9.35B | +3.9% | Beat |
Q1 2025 | $8.88B | $8.94B | -0.7% | Slight Miss |
Q4 2024 | $10.37B | $10.28B | +0.9% | Beat |
Q3 2024 | $9.00B | $8.77B | +2.6% | Beat |
Q2 2024 | $8.36B | $8.37B | -0.1% | In Line |
Pattern: Revenue beats are less consistent than EPS beats (6 of 8 quarters), with two slight misses in Q4 2025 and Q1 2025. Revenue is a less reliable signal given the high pass-through cost content in BOE; EPS is the more meaningful metric for CBRE.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Management raised FY2026 core EPS guidance on the Q1 call (April 23) and has issued no further revisions since. Tone remains constructively confident, with Q2 pipeline described as "stronger than expected" entering the quarter. No post-earnings 8-K or conference update has altered the guidance range.
Metric | Initial Guidance (Q1 2026 Earnings Call, Apr 23) | Revised Guidance | Current Consensus | Note |
FY2026 Core EPS | $7.60–$7.80 (midpoint $7.70); >20% growth | — | $7.72 | Raised from $7.30–$7.60 at Q1 print; no post-earnings revision. Consensus essentially at midpoint. |
Advisory SOP Growth (FY2026) | High-teens % | — | N/A (SOP not directly tracked in VA consensus) | Upgraded from prior guidance at Q1 call; margins described as near 2019 peak steady-state. |
BOE SOP Growth (FY2026) | ~25% (incl. cost reclassification benefit) | — | N/A | High-teens from underlying performance; remainder from lease cost reclassification (D&A neutral to net income). |
Critical Infrastructure Services Revenue Growth (FY2026) | >60% YoY | — | N/A (sub-segment not in VA consensus) | Explicit management target; $1.7B in 2025, $580M in Q1 2026 alone. |
Project Management & REI SOP Growth (FY2026) | Unchanged from prior guidance | — | N/A | No change at Q1 call; development profits pulled forward to Q1 from later quarters (no FY REI impact). |
FCF Conversion (FY2026) | High end of 75–85% target range | — | N/A | Consistent with prior guidance; ~$1.7B TTM FCF as of Q1. |
H1 2026 EPS Mix | ~40% of FY EPS in H1 (above typical seasonality) | — | N/A | Flagged at Q1 call due to Trammell Crow pull-forward; implies H2 weighting is lower than historical norm. |
Source: CBRE Q1 2026 Earnings Call Transcript (April 23, 2026); CBRE Q1 2026 Earnings Release (April 23, 2026); Visible Alpha Consensus Data.
Key Takeaway: Estimates have drifted modestly lower since the post-Q1 baseline across all key KPIs, but the magnitude is small (1–3%) and consensus remains broadly aligned with management's FY guidance midpoint. The drift likely reflects macro caution and the Trammell Crow pull-forward dynamic rather than fundamental deterioration — the gap represents cushion rather than risk if Q2 execution is solid.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (Apr 30, 2026) | Current Estimate (Jul 28, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Adj. EPS — Diluted (Q2 2026) | $1.52 | $1.48 | -2.5% | No specific Q2 guidance | No specific Q2 guidance | N/A | N/A |
Adj. EPS — Diluted (FY2026) | $7.76 | $7.72 | -0.5% | $7.60–$7.80 (midpoint $7.70) | Unchanged | No change | +0.3% above midpoint |
Total Revenue (Q2 2026) | $11.36B | $11.24B | -1.1% | No specific Q2 guidance | No specific Q2 guidance | N/A | N/A |
Total Revenue (FY2026) | $47.11B | $46.83B | -0.6% | No specific FY revenue guidance | No specific FY revenue guidance | N/A | N/A |
Advisory Services Revenue (Q2 2026) | $2.23B | $2.23B | ~0% | High-teens SOP growth (FY) | Unchanged | No change | N/A — SOP guidance |
Adjusted EBITDA (Q2 2026) | $797M | $765M | -4.0% | No specific Q2 guidance | No specific Q2 guidance | N/A | N/A |
Adjusted EBITDA (FY2026) | $3.81B | $3.74B | -1.8% | No specific FY EBITDA guidance | No specific FY EBITDA guidance | N/A | N/A |
The modest downward drift in Q2 EBITDA estimates (-4.0%) is the most notable revision and likely reflects the market adjusting for the Trammell Crow pull-forward effect (development profits shifted from later quarters into Q1). FY2026 EPS consensus of $7.72 sits essentially at the guidance midpoint of $7.70, suggesting the Street is not pricing in meaningful upside or downside to guidance.
Source: Visible Alpha Consensus and Actuals Data. Post-Q1 baseline uses April 30, 2026 as-of date (approximately 5 trading days post-print).
Key Takeaway: CBRE has meaningfully underperformed both XLRE and the S&P 500 since the Q1 print, driven almost entirely by multiple compression (NTM P/E contracted from ~25x to ~21x over six months) rather than estimate cuts. The stock's underperformance despite a guidance raise creates a potentially attractive setup heading into Q2 earnings.
Since the Q1 2026 earnings date (April 23, 2026), CBRE is down approximately -1.5% on an indexed basis vs. XLRE +4.1% and S&P 500 +4.3% (as of July 28, 2026). The stock hit a trough of ~$124 in early June before recovering to ~$144 by late July. The underperformance is notable given the guidance raise and strong Q1 beat, and appears driven by macro uncertainty (tariff concerns, interest rate sensitivity) and the market's skepticism about whether Q1's exceptional infrastructure growth pace is sustainable. The NTM EV/EBITDA multiple has compressed from ~14.2x six months ago to ~12.2x today, a -14% contraction that has more than offset modest estimate revisions.
CBRE vs. XLRE vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings Date (April 23, 2026). Source: Yahoo Finance / Stock Price Data.
Valuation Context:
Multiple | Current (NTM) | 6 Months Ago | Change |
EV / EBITDA | 12.2x | 14.2x | -14.5% |
P / E (NTM) | 20.6x | 25.4x | -18.9% |
EV / Sales | 0.96x | 1.17x | -17.6% |
Source: Stock Price Data (Yahoo Finance); Valuation multiples from Implied platform stock performance decomposition data.
Key Takeaway: Peer commentary from the last 60 days is limited but directionally positive for CBRE. CoStar's Q2 2026 results (reported July 28) confirm healthy CRE demand and accelerating broker engagement. JLL's investment arm commentary (June 30) signals strong conviction in industrial leasing. Cushman & Wakefield's debt refinancing activity (June) is balance-sheet-specific and not a demand read-through.
Scope Note: Only commentary from the last 60 days (on or after May 28, 2026) that addresses Q2 2026 conditions is included below. Q1 2026 earnings commentary from peers (reported in April/May) is excluded as it reflects the prior quarter's results, not the current reporting period.
Relevance: CoStar is the leading CRE data and marketplace platform; its results are a direct read on broker activity, leasing demand, and capital markets engagement.
Source: CoStar Group Q2 2026 Earnings Release and Earnings Call Transcript (July 28, 2026).
Relevance: JLL is CBRE's closest direct peer in CRE services. JLL's investment arm commentary on sector allocation and leasing trends is a direct read-through for CBRE's Advisory and BOE segments.
Source: CNBC / JLL Investment Arm article (June 30, 2026).
Relevance: CWK is a direct CBRE competitor in CRE services. Its Q2 2026 activity was focused on balance sheet management rather than operational commentary.
Source: Cushman & Wakefield 8-K filings (June 4 and June 12, 2026).
Key Takeaway: The most material post-Q1 development is CBRE's new $1B revolving credit facility (June 23), which strengthens liquidity ahead of potential M&A or continued buybacks. No operational pre-announcements or guidance revisions have been issued since the Q1 call.
Key Takeaway: Two insider sales were filed in May 2026, both under pre-established 10b5-1 plans — routine and obligation-driven. No open-market purchases or discretionary sales were identified. Nothing notable to flag.
Name | Title | Transaction Type | Shares | Price | Value | Transaction Date | Filing Date | Note |
Emma E. Giamartino | CFO & Chief Investment Officer | 10b5-1 Planned Sale | 2,250 | $130.74 | ~$294K | May 15, 2026 | May 18, 2026 | Pre-planned 10b5-1 sale; routine / obligation-driven |
Chad J. Doellinger | Chief Legal & Admin. Officer | 10b5-1 Planned Sale | 107 | $140.35 | ~$15K | May 5, 2026 | May 5, 2026 | Pre-planned 10b5-1 sale; de minimis size |
Both transactions were executed under Rule 10b5-1(c) pre-planned trading programs. The CFO sale of 2,250 shares (~$294K) is small relative to her remaining position of 110,729 shares. The CLO sale of 107 shares (~$15K) is de minimis. Neither transaction is discretionary or signals any change in insider sentiment. No open-market purchases were identified in the period.
Source: SEC Form 4 filings — Giamartino (filed May 18, 2026); Doellinger (filed May 5, 2026). Insider Transaction Data (SEC EDGAR).
Note: The company separately disclosed ~$540M in share repurchases YTD as of April 21, 2026 (at an average price of ~$148), reflecting strong corporate-level conviction in the stock at prices above current levels.